Healthcare & Life Sciences
AnaCardio
Swedenanacardio.com
AnaCardio is a Healthcare & Life Sciences startup based in Sweden, most recent round Series A, 3 tracked investors.
activeseries-a
series-a
Stage
2020
Founded
3
Investors
About AnaCardio
Based in Sweden, AnaCardio is a startup founded in 2020. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
AnaCardio is a clinical-stage biopharmaceutical company developing novel drugs to treat heart failure, focusing on improving cardiac contractility through a unique mechanism based on the ghrelin signaling pathway.
Explore AnaCardio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.